Your browser doesn't support javascript.
loading
Open-label, randomised, clinical trial to evaluate the immunogenicity and safety of a prophylactic vaccination of healthcare providers by administration of a heterologous vaccine regimen against Ebola in the Democratic Republic of the Congo: the study protocol.
Larivière, Ynke; Zola, Trésor; Stoppie, Elke; Maketa, Vivi; Matangila, Junior; Mitashi, Patrick; De Bie, Jessie; Muhindo-Mavoko, Hypolite; Van Geertruyden, Jean-Pierre; Van Damme, Pierre.
Afiliación
  • Larivière Y; Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium ynke.lariviere@uantwerpen.be.
  • Zola T; Global Health Institute, University of Antwerp, Wilrijk, Belgium.
  • Stoppie E; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the).
  • Maketa V; Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
  • Matangila J; Global Health Institute, University of Antwerp, Wilrijk, Belgium.
  • Mitashi P; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the).
  • De Bie J; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the).
  • Muhindo-Mavoko H; Tropical Medicine Department, University of Kinshasa, Kinshasa, Congo (the Democratic Republic of the).
  • Van Geertruyden JP; Centre for Evaluation of Vaccination, University of Antwerp, Wilrijk, Belgium.
  • Van Damme P; Global Health Institute, University of Antwerp, Wilrijk, Belgium.
BMJ Open ; 11(9): e046835, 2021 09 28.
Article en En | MEDLINE | ID: mdl-34588237

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Bélgica

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Fiebre Hemorrágica Ebola / Vacunas contra el Virus del Ébola Tipo de estudio: Clinical_trials / Guideline Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: BMJ Open Año: 2021 Tipo del documento: Article País de afiliación: Bélgica